Revisiting the chaperonin T‐complex protein‐1 ring complex in human health and disease: A proteostasis modulator and beyond
Chenglong Zeng,Shenqi Han,Yonglong Pan,Zhao Huang,Binhao Zhang,Bixiang Zhang
DOI: https://doi.org/10.1002/ctm2.1592
IF: 8.554
2024-02-18
Clinical and Translational Medicine
Abstract:1. The roles of cytosolic T‐complex protein‐1 ring complex (TRiC/CCT) in physiological and pathological processes are updated. 2. Except for modulating proteostasis as a chaperonin, TRiC/CCT regulates cell cycle, transcription and translation initiation, immortality, epigenetic changes, T‐cell immunity, autophagy and signal transduction. 3. TRiC/CCT dysfunction leads to various clinical disorders, and displays the potential to serve as an effective marker and target for pharmacological intervention for various diseases. Background Disrupted protein homeostasis (proteostasis) has been demonstrated to facilitate the progression of various diseases. The cytosolic T‐complex protein‐1 ring complex (TRiC/CCT) was discovered to be a critical player in orchestrating proteostasis by folding eukaryotic proteins, guiding intracellular localisation and suppressing protein aggregation. Intensive investigations of TRiC/CCT in different fields have improved the understanding of its role and molecular mechanism in multiple physiological and pathological processes. Main body In this review, we embark on a journey through the dynamic protein folding cycle of TRiC/CCT, unraveling the intricate mechanisms of its substrate selection, recognition, and intriguing folding and assembly processes. In addition to discussing the critical role of TRiC/CCT in maintaining proteostasis, we detail its involvement in cell cycle regulation, apoptosis, autophagy, metabolic control, adaptive immunity and signal transduction processes. Furthermore, we meticulously catalogue a compendium of TRiC‐associated diseases, such as neuropathies, cardiovascular diseases and various malignancies. Specifically, we report the roles and molecular mechanisms of TRiC/CCT in regulating cancer formation and progression. Finally, we discuss unresolved issues in TRiC/CCT research, highlighting the efforts required for translation to clinical applications, such as diagnosis and treatment. Conclusion This review aims to provide a comprehensive view of TRiC/CCT for researchers to inspire further investigations and explorations of potential translational possibilities.
oncology,medicine, research & experimental